FHTX vs ZBH · rev $19.3M vs P/E 23, rev $4.26B
Foghorn Therapeutics Inc (FHTX) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
FHTX currently screens at market cap $237.8M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the FHTX and ZBH stock pages for the full models.
Not investment advice.